Jackson Square Capital LLC Has $618,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jackson Square Capital LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 74.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,247 shares of the medical equipment provider’s stock after selling 3,545 shares during the period. Jackson Square Capital LLC’s holdings in Intuitive Surgical were worth $618,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ISRG. BNC Wealth Management LLC lifted its holdings in Intuitive Surgical by 0.6% during the 1st quarter. BNC Wealth Management LLC now owns 11,211 shares of the medical equipment provider’s stock valued at $5,552,000 after purchasing an additional 63 shares during the last quarter. Azzad Asset Management Inc. ADV raised its position in shares of Intuitive Surgical by 1.8% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 7,105 shares of the medical equipment provider’s stock valued at $3,519,000 after acquiring an additional 125 shares during the last quarter. Goldstone Financial Group LLC boosted its holdings in Intuitive Surgical by 63.2% during the first quarter. Goldstone Financial Group LLC now owns 837 shares of the medical equipment provider’s stock worth $415,000 after buying an additional 324 shares during the last quarter. Ipswich Investment Management Co. Inc. raised its holdings in Intuitive Surgical by 4.0% in the first quarter. Ipswich Investment Management Co. Inc. now owns 1,048 shares of the medical equipment provider’s stock worth $519,000 after purchasing an additional 40 shares during the period. Finally, CVA Family Office LLC increased its position in shares of Intuitive Surgical by 6.4% during the first quarter. CVA Family Office LLC now owns 678 shares of the medical equipment provider’s stock worth $336,000 after acquiring an additional 41 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now directly owns 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $512.18 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The firm has a fifty day moving average price of $526.57 and a 200 day moving average price of $538.46. The firm has a market cap of $183.57 billion, a price-to-earnings ratio of 79.90, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the firm posted $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.